EP1651270B1 — Medicaments for inhalation comprising betamimetics and an anticholinergic
Assigned to Boehringer Ingelheim International GmbH · Expires 2007-03-21 · 19y expired
What this patent protects
The present invention relates to novel pharmaceutical compositions based on beta 2 agonists and salts of an anticholinergic, processes for preparing them and their use in the treatment of respiratory complaints.
USPTO Abstract
The present invention relates to novel pharmaceutical compositions based on beta 2 agonists and salts of an anticholinergic, processes for preparing them and their use in the treatment of respiratory complaints.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.